ArticleTherapeutic advances in medical oncology2021

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.

Alessandro Ottaiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.